Our resource hub is home to a wealth of articles, stories and videos about managing and living with type 1 diabetes.
Place your order for our free information packs that support adults and children who have been recently diagnosed.
Our researchers are working on different ways to develop a cure for type 1 diabetes - from growing insulin-producing beta cells in labs to hacking the immune system.
Learn about the technologies that can deliver insulin automatically when needed. And discover the next generation of insulins that are currently being developed.
We have a wide range of fun and festive designs to choose from. Fund life changing research while spreading joy this Christmas!
This Christmas, your gift can bring us closer to a cure for type 1 diabetes – and every pound you give to our Christmas Appeal will be doubled.
The announcement is the biggest treatment breakthrough for type 1 diabetes since the discovery of insulin.
This event is designed for anyone living with type 1 diabetes who would like to learn more about managing their wellbeing across a variety of contexts.
We provide a wealth of information and free resources to help you support and empower your patients or students.
Take our free course for schools to learn more about supporting pupils with type 1 diabetes in educational settings.
Home > Pathway to Choice
A range of wearable medical devices already exists to help manage type 1 diabetes, which can be a challenging condition to live with.
However, only a small percentage of those living with the condition in the UK use these more technology-based treatments.
And currently, just 30% of people with type 1 diabetes reach their recommended blood glucose targets, putting them at greater risk of health complications.
People with type 1 diabetes who use medical technologies may find it easier to manage their glucose levels and thereby reduce these health risks.
JDRF commissioned market research to understand the motivations and barriers people with type 1 diabetes face in making treatment choices.
The findings of our Pathway to Choice report, launched in February 2020, will enable us to explore the types of support and interventions we can develop to help people living with type 1 diabetes choose the best possible treatments.
The market research also highlighted areas in which government, the Department of Health and Social Care and the NHS can improve support for people living with this life-changing condition.
Read the full Pathway to Choice report or download the executive summary.
Pathway to Choice is a partnership programme led by JDRF and supported by industry partners Abbott Diabetes Care, Dexcom, Insulet International Ltd and Roche Diabetes Care Ltd.
The aim of the programme is to build awareness of and access to type 1 technology choices for people with type 1 diabetes. It does this through building insight to influence health decision-makers, increasing understanding of technologies among people with type 1 diabetes and raising public awareness of type 1 diabetes and its treatment.
“I am privileged to have been involved in many trials over the years and it is incredible to see how far research has come in a short time. I was once on a trial with a primitive insulin pump so the fact we’re now starting to see closed-loop insulin delivery systems come to market is a testament to the fact that research is the only way forward. I am excited to have played my part in it.”
Learn more about the types of support and interventions we can develop to help people living with type 1 diabetes choose the best possible treatments.